Translational Development Acquisition Corp. · NASDAQ:TDAC
Wolverine Asset Management LLC reported a 9.03% stake in Translational Development Acquisition Corp. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Oct 10, 2025
Wolverine Asset Management LLC reported a 9.03% stake in Translational Development Acquisition Corp., 1,557,134 shares, as a passive investor on Sep 30, 2025. Filed Oct 10, 2025 (Schedule 13G/A).
- Stake
- 9.03%
- Shares
- 1,557,134
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC | 9.03% | 1,557,134 |
| Wolverine Trading Partners, Inc. | 9.03% | 1,557,134 |
| Wolverine Holdings, L.P. | 9.03% | 1,557,134 |
| Christopher L. Gust | 9.03% | 1,557,134 |
| Robert R. Bellick | 9.03% | 1,557,134 |
Source
Related
- Translational Development Acquisition Corp.
- Wolverine Asset Management LLC
- Translational Development Acquisition Corp. shareholders
- Schedule 13G/A · Wolverine Asset Management LLC · Jul 16, 2026
- Schedule 13G/A · Wolverine Asset Management LLC · Jul 11, 2025
- Schedule 13G · Wolverine Asset Management LLC · May 1, 2025
- Schedule 13G/A · Linden Advisors LP · Aug 14, 2026
- Schedule 13G · Meteora Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · Aug 12, 2026
- Schedule 13G · Linden Advisors LP · Jun 2, 2026
- Schedule 13G · Goldman Sachs Group Inc · May 13, 2026